THU551 Glycoprotein-NMB (GPNMB) Is A Potential Lymphangioleiomyomatosis (LAM) Therapeutic Target And Biomarker

Disclosure: E. Gibbons: None. S.R. Hammes: None. Lymphangioleiomyomatosis (LAM) is a rare, progressive, destructive cystic lung disease affecting almost exclusively female-sexed individuals. Mutations in the tuberous sclerosis (TSC1 or TSC2) genes constitutively activate the mTORC1 pathway, promotin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibbons, Erin, Taya, Manisha, Wu, Huixing, McCormack, Francis X, Hammes, Stephen R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554134/
http://dx.doi.org/10.1210/jendso/bvad114.2177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554134/
http://dx.doi.org/10.1210/jendso/bvad114.2177

Ejemplares similares